Baxter Healthcare Corporation vs Boehringer Ingelheim Pharmaceuticals, Inc.: FDA Enforcement Comparison

Baxter Healthcare Corporation has been the subject of 209 FDA enforcement/approval records tracked by Argus HQ, compared to 2 for Boehringer Ingelheim Pharmaceuticals, Inc..

Baxter Healthcare Corporation: 0 warning letters, 209 recalls, 0 approval records, 0 Form 483s.

Boehringer Ingelheim Pharmaceuticals, Inc.: 0 warning letters, 2 recalls, 0 approval records, 0 Form 483s.

Side by side

Baxter Healthcare Corporation — Warning letters0

Boehringer Ingelheim Pharmaceuticals, Inc. — Warning letters0

Baxter Healthcare Corporation — Recalls209

Boehringer Ingelheim Pharmaceuticals, Inc. — Recalls2

Baxter Healthcare Corporation — Approval records0

Boehringer Ingelheim Pharmaceuticals, Inc. — Approval records0

Baxter Healthcare Corporation — Form 483s0

Boehringer Ingelheim Pharmaceuticals, Inc. — Form 483s0

Timeline

Baxter Healthcare Corporation

Most recent FDA action: August 19, 2026

Full history →

Boehringer Ingelheim Pharmaceuticals, Inc.

Most recent FDA action: July 8, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Baxter Healthcare Corporation vs Boehringer Ingelheim Pharmaceuticals, Inc.: FDA Enforcement Comparison." Argus HQ, accessed August 29, 2026. https://argushq.ai/compare/baxter-healthcare-corporation-vs-boehringer-ingelheim-pharmaceuticals-inc

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗